254 related articles for article (PubMed ID: 11287611)
1. Inhibition of cellular proliferation through IkappaB kinase-independent and peroxisome proliferator-activated receptor gamma-dependent repression of cyclin D1.
Wang C; Fu M; D'Amico M; Albanese C; Zhou JN; Brownlee M; Lisanti MP; Chatterjee VK; Lazar MA; Pestell RG
Mol Cell Biol; 2001 May; 21(9):3057-70. PubMed ID: 11287611
[TBL] [Abstract][Full Text] [Related]
2. The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma.
Giri S; Rattan R; Singh AK; Singh I
J Immunol; 2004 Oct; 173(8):5196-208. PubMed ID: 15470065
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; Iñiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-Delta(12,14)-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways.
Zingarelli B; Sheehan M; Hake PW; O'Connor M; Denenberg A; Cook JA
J Immunol; 2003 Dec; 171(12):6827-37. PubMed ID: 14662889
[TBL] [Abstract][Full Text] [Related]
5. 15-Deoxy-Delta(12,14)-prostaglandin J(2) induces G(1) arrest and differentiation marker expression in vascular smooth muscle cells.
Miwa Y; Sasaguri T; Inoue H; Taba Y; Ishida A; Abumiya T
Mol Pharmacol; 2000 Oct; 58(4):837-44. PubMed ID: 10999955
[TBL] [Abstract][Full Text] [Related]
6. 15-Deoxy-delta(12,14)-prostaglandin J(2) inhibits IL-1beta-induced IKK enzymatic activity and IkappaBalpha degradation in rat chondrocytes through a PPARgamma-independent pathway.
Boyault S; Bianchi A; Moulin D; Morin S; Francois M; Netter P; Terlain B; Bordji K
FEBS Lett; 2004 Aug; 572(1-3):33-40. PubMed ID: 15304320
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator--activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes.
Fahmi H; Di Battista JA; Pelletier JP; Mineau F; Ranger P; Martel-Pelletier J
Arthritis Rheum; 2001 Mar; 44(3):595-607. PubMed ID: 11263774
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor gamma ligands differentially modulate muscle cell differentiation and MyoD gene expression via peroxisome proliferator-activated receptor gamma -dependent and -independent pathways.
Hunter JG; van Delft MF; Rachubinski RA; Capone JP
J Biol Chem; 2001 Oct; 276(41):38297-306. PubMed ID: 11477074
[TBL] [Abstract][Full Text] [Related]
9. Activation of peroxisome proliferator-activated receptor gamma inhibits interleukin-1beta-induced membrane-associated prostaglandin E2 synthase-1 expression in human synovial fibroblasts by interfering with Egr-1.
Cheng S; Afif H; Martel-Pelletier J; Pelletier JP; Li X; Farrajota K; Lavigne M; Fahmi H
J Biol Chem; 2004 May; 279(21):22057-65. PubMed ID: 15023995
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor gamma activation modulates cyclin D1 transcription via beta-catenin-independent and cAMP-response element-binding protein-dependent pathways in mouse hepatocytes.
Sharma C; Pradeep A; Pestell RG; Rana B
J Biol Chem; 2004 Apr; 279(17):16927-38. PubMed ID: 14764597
[TBL] [Abstract][Full Text] [Related]
11. PPARgamma ligands inhibit cholangiocarcinoma cell growth through p53-dependent GADD45 and p21 pathway.
Han C; Demetris AJ; Michalopoulos GK; Zhan Q; Shelhamer JH; Wu T
Hepatology; 2003 Jul; 38(1):167-77. PubMed ID: 12829999
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells.
Hashimoto K; Ethridge RT; Evers BM
Int J Gastrointest Cancer; 2002; 32(1):7-22. PubMed ID: 12630765
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene.
Li M; Pascual G; Glass CK
Mol Cell Biol; 2000 Jul; 20(13):4699-707. PubMed ID: 10848596
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivation.
Wang C; Pattabiraman N; Zhou JN; Fu M; Sakamaki T; Albanese C; Li Z; Wu K; Hulit J; Neumeister P; Novikoff PM; Brownlee M; Scherer PE; Jones JG; Whitney KD; Donehower LA; Harris EL; Rohan T; Johns DC; Pestell RG
Mol Cell Biol; 2003 Sep; 23(17):6159-73. PubMed ID: 12917338
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of interleukin-4 production in CD4+ T cells by peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands: involvement of physical association between PPAR-gamma and the nuclear factor of activated T cells transcription factor.
Chung SW; Kang BY; Kim TS
Mol Pharmacol; 2003 Nov; 64(5):1169-79. PubMed ID: 14573767
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo.
Xin X; Yang S; Kowalski J; Gerritsen ME
J Biol Chem; 1999 Mar; 274(13):9116-21. PubMed ID: 10085162
[TBL] [Abstract][Full Text] [Related]
17. 15-Deoxy-delta12,14-PGJ2, but not troglitazone, modulates IL-1beta effects in human chondrocytes by inhibiting NF-kappaB and AP-1 activation pathways.
Boyault S; Simonin MA; Bianchi A; Compe E; Liagre B; Mainard D; Bécuwe P; Dauça M; Netter P; Terlain B; Bordji K
FEBS Lett; 2001 Jul; 501(1):24-30. PubMed ID: 11457450
[TBL] [Abstract][Full Text] [Related]
18. 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway.
Straus DS; Pascual G; Li M; Welch JS; Ricote M; Hsiang CH; Sengchanthalangsy LL; Ghosh G; Glass CK
Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4844-9. PubMed ID: 10781090
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes.
Yamamoto K; Ohki R; Lee RT; Ikeda U; Shimada K
Circulation; 2001 Oct; 104(14):1670-5. PubMed ID: 11581147
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor gamma ligands inhibit retinoblastoma phosphorylation and G1--> S transition in vascular smooth muscle cells.
Wakino S; Kintscher U; Kim S; Yin F; Hsueh WA; Law RE
J Biol Chem; 2000 Jul; 275(29):22435-41. PubMed ID: 10801895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
